These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 710805)

  • 61. Saturation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate accumulation in leukemia cells during high-dose 1-beta-D-arabinofuranosylcytosine therapy.
    Plunkett W; Liliemark JO; Adams TM; Nowak B; Estey E; Kantarjian H; Keating MJ
    Cancer Res; 1987 Jun; 47(11):3005-11. PubMed ID: 3471322
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pharmacology of 5'-esters of 1-beta-D-arabinofuranosylcytosine.
    Ho DH; Neil GL
    Cancer Res; 1977 Jun; 37(6):1640-3. PubMed ID: 870178
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Concordant changes of pyrimidine metabolism in blasts of two cases of acute myeloid leukemia after repeated treatment with ara-C in vivo.
    Chiba P; Tihan T; Szekeres T; Salamon J; Kraupp M; Eher R; Köller U; Knapp W
    Leukemia; 1990 Nov; 4(11):761-5. PubMed ID: 2232889
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Resistance to 9-beta-D-arabinofuranosyladenine in cultured leukemia L 1210 cells.
    Cass CE; Selner M; Phillips JR
    Cancer Res; 1983 Oct; 43(10):4791-8. PubMed ID: 6603904
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Intracellular cytarabine triphosphate production correlates to deoxycytidine kinase/cytosolic 5'-nucleotidase II expression ratio in primary acute myeloid leukemia cells.
    Yamauchi T; Negoro E; Kishi S; Takagi K; Yoshida A; Urasaki Y; Iwasaki H; Ueda T
    Biochem Pharmacol; 2009 Jun; 77(12):1780-6. PubMed ID: 19428333
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Synergistic interaction between etoposide and 1-beta-D-arabinofuranosylcytosine.
    Ohkubo T; Hori H; Higashigawa M; Kawasaki H; Kamiya H; Sakurai M; Kagawa Y; Kakito E; Sumida K; Ooi K
    Adv Exp Med Biol; 1989; 253B():355-62. PubMed ID: 2610123
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Dose-dependent cytokinetic changes following 1-beta-D-arabinofuranosylcytosine and hydroxyurea in L1210 and S-180 in vivo.
    Straus MJ; Moran RE
    Cell Tissue Kinet; 1978 Sep; 11(5):529-42. PubMed ID: 299719
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The relationship of Ara-C metabolism in vitro to therapeutic response in acute myeloid leukaemia.
    Harris AL; Grahame-Smith DG
    Cancer Chemother Pharmacol; 1982; 9(1):30-5. PubMed ID: 6958391
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Role of DNA repair in natural resistance of rat ascites hepatomas to nitrogen mustard.
    Inaba M; Sakurai Y
    Gan; 1977 Feb; 68(1):15-9. PubMed ID: 193752
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Thromboplastic and fibrinolytic activities of ascites tumor cells of rats, with reference to their role in metastasis formation.
    Kohga S
    Gan; 1978 Aug; 69(4):461-70. PubMed ID: 710800
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Enhancement of chemotherapeutic effect by entrapping 1-beta-D-arabinofuranosylcytosine in lipid vesicles and its mode of action.
    Kataoka T; Kobayashi T
    Ann N Y Acad Sci; 1978; 308():387-94. PubMed ID: 279298
    [TBL] [Abstract][Full Text] [Related]  

  • 72. In vitro metabolism of 1-beta-D-arabinofuranosylcytosine and 1-beta-2'-fluoroarabino-5-iodocytosine in normal and herpes simplex type 1 virus-infected cells.
    Kreis W; Damin L; Colacino J; Lopez C
    Biochem Pharmacol; 1982 Mar; 31(5):767-73. PubMed ID: 7082345
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Experimental study of an anticancer drug delivery system using polylactic acid].
    Yamashita R
    Nihon Geka Gakkai Zasshi; 1987 Apr; 88(4):401-12. PubMed ID: 3587219
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Dephosphorylation of nucleotides of 1-beta-D-arabinofuranosylcytosine in relation to the different drug sensitivity in tumor cells.
    Abe I; Sato H
    Tohoku J Exp Med; 1979 Mar; 127(3):281-8. PubMed ID: 442078
    [No Abstract]   [Full Text] [Related]  

  • 75. [Biological effect of bestatin against rat ascites hepatomas and enhancement of interferon production].
    Satoh H
    Jpn J Antibiot; 1984 Apr; 37(4):593-6. PubMed ID: 6206251
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Antitumor activity of a new amino acid derivative, N6,N9-bis-(butyloxycarbonylaminomethyl)-L-citrulline.
    Fujita H; Seto Y; Sakurai T; Ichimura H; Satoh H; Toyoshima S
    Gan; 1978 Feb; 69(1):99-101. PubMed ID: 205478
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Action of cytosine arabinoside on human tumor cells isolated from malignant effusions: in vitro phosphorylation and inhibition of DNA synthesis.
    Stahel RA; Peter HJ; Sauter C
    Med Pediatr Oncol; 1979; 6(4):303-11. PubMed ID: 481320
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Transport and phosphorylation as factors in the antitumor action of cytosine arabinoside.
    Kessel D; Hall TC; Wodinsky I
    Science; 1967 Jun; 156(3779):1240-1. PubMed ID: 6025544
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Combination effect of bis(3-methylsulfonyloxypropyl)amide and 6-mercaptopurine on AH-60C and AH-109A.
    Imamura H; Okumoto T
    Gan; 1975 Feb; 66(1):95-7. PubMed ID: 168116
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cytoplasmic microtubules of rat ascites hepatoma cells.
    Sato T; Ariji F; Takusagawa K; Shida K; Asoo N; Konno K; Sato H
    Tohoku J Exp Med; 1981 Jul; 134(3):311-9. PubMed ID: 7314108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.